| Financial Year |
March 31 2023 |
| Monetary Funds |
689,922,521.41 |
| Held-for-trading Financial Assets |
2,300,000.00 |
| Notes Receivable |
65,891,907.00 |
| Accounts Receivable |
290,314,900.20 |
| Advances to Suppliers |
13,173,959.44 |
| Other Receivables |
8,105,260.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
510,823,104.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
82,292,292.09 |
| Total Current Assets |
1,953,998,677.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
54,918,182.09 |
| Investment Properties |
36,763,477.23 |
| Fixed Assetes |
1,438,472,342.68 |
| Under-construction Projects |
820,197,754.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
248,073,415.30 |
| R&D expenses |
-- |
| Goodwill |
1,146,675.95 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
28,650,107.59 |
| Other Non-Current Assets |
46,847,392.63 |
| Sub-Total of Non-Current Assets |
2,911,367,634.18 |
| Total Assets |
4,865,366,311.20 |
| Short-Term Loans |
515,313,750.00 |
| Trading Financial liabilities |
626,345.00 |
| Notes Payable |
281,114,528.18 |
| Accounts Payable |
244,979,803.65 |
| Accounts Received In Advance |
372,902.70 |
| Employee Compensation Payable |
18,601,388.57 |
| Taxes Payable |
16,946,125.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,719,630.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,956,000.00 |
| Other Current Liabilities |
47,088,033.01 |
| Sub-Total of Current Liabilities |
1,176,015,009.43 |
| Long-term Loans |
962,044,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,246,144.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,031,849,315.14 |
| Total Liabilities |
2,207,864,324.57 |
| Paid-In Capital(Or Share Stock) |
550,004,834.00 |
| Capital Surplus |
1,408,754,847.33 |
| Surplus Reserve |
144,261,996.51 |
| LESS:Treasury Stock |
174,858,651.95 |
| Undistributed Profits |
707,269,603.96 |
| Minority Stockholder's Interest |
4,953,367.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,652,548,619.17 |
| Owner's Equity（Stockholder's Equity） |
2,657,501,986.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,865,366,311.20 |
